PL
REGN icon

Plancorp LLC’s Regeneron Pharmaceuticals REGN Stock Holding History

Plancorp LLC’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$601K Sell
907
-19
-2% -$12.9K 0.01% 227
2026
Q1 		$693K Buy
926
+2
+0.2% +$1.53K 0.02% 187
2025
Q4 		$713K Buy
924
+65
+8% +$44.1K 0.02% 181
2025
Q3 		$483K Sell
859
-21
-2% -$11.9K 0.02% 228
2025
Q2 		$462K Sell
880
-17
-2% -$9.49K 0.02% 235
2025
Q1 		$569K Sell
897
-2
-0.2% -$1.38K 0.02% 190
2024
Q4 		$640K Sell
899
-22
-2% -$18.5K 0.03% 165
2024
Q3 		$968K Buy
921
+3
+0.3% +$3.34K 0.04% 133
2024
Q2 		$965K Buy
918
+8
+0.9% +$7.75K 0.04% 124
2024
Q1 		$876K Buy
910
+12
+1% +$11.4K 0.04% 130
2023
Q4 		$789K Buy
898
+20
+2% +$16.5K 0.04% 125
2023
Q3 		$723K Buy
878
+11
+1% +$8.64K 0.04% 128
2023
Q2 		$623K Sell
867
-1
-0.1% -$771 0.03% 137
2023
Q1 		$713K Sell
868
-34
-4% -$25.6K 0.04% 129
2022
Q4 		$651K Buy
902
+3
+0.3% +$2.21K 0.04% 129
2022
Q3 		$619K Buy
899
+23
+3% +$14.5K 0.04% 124
2022
Q2 		$518K Sell
876
-1,400
-62% -$910K 0.03% 146
2022
Q1 		$1.59M Buy
2,276
+17
+0.8% +$10.8K 0.1% 81
2021
Q4 		$1.43M Buy
2,259
+39
+2% +$24K 0.09% 80
2021
Q3 		$1.34M Buy
2,220
+3
+0.1% +$1.86K 0.09% 76
2021
Q2 		$1.24M Hold
2,217
– – 0.1% 78
2021
Q1 		$1.05M Hold
2,217
– – 0.23% 74
2020
Q4 		$1.07M Sell
2,217
-303
-12% -$164K 0.26% 70
2020
Q3 		$1.41M Buy
+2,520
New +$1.53M 0.43% 46

Other funds holding REGN

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return

Plancorp LLC's REGN Position: Q2 2026 in Review

Plancorp LLC reduced its Regeneron Pharmaceuticals (REGN) stake by 2.1% in Q2 2026, selling an estimated $12.9K and leaving 907 shares worth $601K. The position accounts for 0.01% of the portfolio, ranked #227.

Plancorp LLC first reported a position in REGN in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.59M in Q1 2022. 298 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Plancorp LLC held 907 shares of Regeneron Pharmaceuticals worth $601K as of Q2 2026.
  • Plancorp LLC sold 19 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $12.9K.
  • Regeneron Pharmaceuticals made up 0.01% of Plancorp LLC's portfolio in Q2 2026, its #227 holding.
  • Plancorp LLC first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 24 quarters since.
  • Plancorp LLC's Regeneron Pharmaceuticals position peaked at $1.59M in Q1 2022.
  • 298 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Plancorp LLC's 13F filing for Q2 2026, filed 14 Jul 2026.